SPF 4 in a bottle labelled SPF50+ — and the TGA audit found nothing wrong

What just happened

Wild Child Laboratories manufactured the base formula used in 20 sunscreen products recalled by the Therapeutic Goods Administration. Independent testing commissioned by the affected brands returned alarming results: SPF readings of 2.9, 3.0, 3.6, 4.1, 10.5, 21.5, and 25.18 from products labelled SPF50+. The TGA’s own assessment determined the Wild Child formulation was unlikely to exceed SPF 21, with some products as low as SPF 4.

The affected brands include Ultra Violette (Lean Screen SPF50+), Aspect Skincare, Naked Sundays, and Advanced Skin Technology, among fifteen others. Ultra Violette is seeking millions in damages. Advanced Skin Technology has claimed approximately $2.5 million in losses. Total creditor claims against Wild Child reach approximately $20 million.

Wild Child Laboratories entered voluntary liquidation in August 2026. The month before liquidation, it sold assets to a new company — Heliora — which shares the same chief executive and director, raising questions about what remains available to creditors.

The TGA conducted a Good Manufacturing Practice audit of Wild Child. It found no manufacturing issues.

Both-and

The TGA system is real — and this case shows where its limits sit

The Therapeutic Goods Administration’s pathway for listed therapeutic goods — including sunscreens registered on the Australian Register of Therapeutic Goods — assesses safety and quality of manufacture, and requires manufacturers to hold evidence supporting their product claims. What it does not do is independently verify SPF performance before a product reaches market. Listed medicines and sunscreens are not batch-tested by the TGA. The SPF claim on the label is substantiated by the manufacturer’s evidence — not by a government test.

That means the first line of protection is the manufacturer’s own testing. The second line is post-market surveillance and mandatory reporting when problems emerge. In this case, the problem emerged when the brands themselves commissioned independent testing — and found their products were not what the label said they were. The TGA GMP audit checked whether the manufacturing environment and documentation met quality standards. It found they did. A clean GMP audit is not the same as an effective product.

The gap between a compliant factory and a product delivering its claimed SPF is real, and this case has landed squarely in it. The ARTG listing that reassured everyone that this product was “regulated” and “safe” did not catch an SPF4 outcome in a bottle labelled SPF50+.

Australia’s skin cancer context is not a hypothetical background

Australia has one of the highest rates of skin cancer in the world. Approximately two in three Australians are diagnosed with some form of skin cancer by age 70. Cancer Council’s five-step UV protection approach places SPF50+ as the standard because Australian UV conditions are consistently severe — a UV Index of 10 to 14+ in summer is common across all major cities.

SPF50+ blocks approximately 98% of UVB radiation. SPF4 blocks approximately 75%. The arithmetic of that gap matters over time. A person who believed they were wearing SPF50+ through an Australian summer — every day, properly applied, with the confidence of an ARTG-listed product — and was in fact wearing SPF4, received materially different UV protection. Not dramatically less on any given day. Substantially less across months and years of cumulative UV exposure.

The brands affected — Ultra Violette, Naked Sundays, Aspect — are popular with exactly the demographic most likely to take UV protection seriously. That is the particular problem here. The people who were being careful, who chose an SPF50+ product, who read the label and trusted the TGA listing, were carrying significantly less protection than they thought.

The liquidation timing

Wild Child entered voluntary liquidation in August 2026. In July 2026, it sold assets to Heliora, a company with the same CEO and director. The legal proceedings brought by Ultra Violette and Advanced Skin Technology will determine how those transactions are characterised and whether creditors have access to the transferred assets. Total claims are approximately $20 million against a company that has been dissolved.

The pattern — product failure identified, assets sold to a related entity, company liquidated — is one creditors and regulators will scrutinise. The legal proceedings are ongoing.

2 cents

Two practical points from this case:

Check whether your sunscreen was recalled. The TGA maintains a recall database at tga.gov.au. If your product is listed, replace it with a product from a different manufacturer’s formulation. Ultra Violette and other affected brands have reformulated or sourced alternative base formulas — check their own communications for the current status of their product lines.

The ARTG listing is a minimum standard, not a performance guarantee. A sunscreen with an ARTG listing has cleared a meaningful regulatory bar — safety assessment, quality manufacturing documentation, evidence held by the manufacturer. For the vast majority of products from established manufacturers, the label is accurate. This case illustrates that the system relies on manufacturers providing accurate evidence and testing — and that when they don’t, post-market detection can be slow and arrive through civil litigation rather than proactive surveillance.

Skin cancer prevention in Australia is a long game. The disruption here is real for people who trusted these products. It is not a reason to stop wearing sunscreen. It is a reason to replace a recalled product and, for those with persistent questions, to confirm the formulation of your chosen replacement with its manufacturer directly.

Verdict: yes — worth knowing about. Australian UV conditions make SPF choice consequential. SPF4 in a bottle labelled SPF50+ is not a minor discrepancy.

---

Sources cited

1. Company behind pulled sunscreens sued for ‘misleading’ conduct. ABC News Health, 10 September 2026.